- 2026-12-06
-
BRCA1/2 mutation characteristics and first-line PARP inhibitor maintenance therapy efficacy in advanced ovarian cancer: a multicenter real-world study
07:39-07:46
Room 502
Mini Oral
Speaker

Qingxiu Jiang
BRCA1/2 mutation characteristics and first-line PARP inhibitor maintenance therapy efficacy in advanced ovarian cancer: a multicenter real-world study
07:39-07:46
Room 502
Mini Oral
Speaker